NCT05980416 2025-11-14Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2Elevation OncologyPhase 1 Terminated88 enrolled 18 charts
NCT04171141 2025-01-16Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.PfizerPhase 1 Terminated79 enrolled 42 charts